| Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary J Vestbo, SS Hurd, AG Agustí, PW Jones, C Vogelmeier, A Anzueto, ... American journal of respiratory and critical care medicine 187 (4), 347-365, 2013 | 6948 | 2013 |
| Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary CF Vogelmeier, GJ Criner, FJ Martinez, A Anzueto, PJ Barnes, ... American journal of respiratory and critical care medicine 195 (5), 557-582, 2017 | 5330 | 2017 |
| Chronic obstructive pulmonary disease phenotypes: the future of COPD MLK Han, A Agusti, PM Calverley, BR Celli, G Criner, JL Curtis, LM Fabbri, ... American journal of respiratory and critical care medicine 182 (5), 598-604, 2010 | 1559 | 2010 |
| Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations A Papi, CM Bellettato, F Braccioni, M Romagnoli, P Casolari, G Caramori, ... American journal of respiratory and critical care medicine 173 (10), 1114-1121, 2006 | 1433 | 2006 |
| Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults PJ Sterk, LM Fabbri, PH Quanjer, DW Cockcroft, PM O'Byrne, ... European Respiratory Journal 6 (Suppl 16), 53-83, 1993 | 1389 | 1993 |
| CD8+ T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease M Saetta, A Di STEFANO, G Turato, FM Facchini, L Corbino, CE Mapp, ... American journal of respiratory and critical care medicine 157 (3), 822-826, 1998 | 1203 | 1998 |
| Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials PMA Calverley, KF Rabe, UM Goehring, S Kristiansen, LM Fabbri, ... The Lancet 374 (9691), 685-694, 2009 | 1141 | 2009 |
| Complex chronic comorbidities of COPD LM Fabbri, F Luppi, B Beghé, KF Rabe European Respiratory Journal 31 (1), 204-212, 2007 | 1070 | 2007 |
| Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma J Bousquet, E Mantzouranis, AA Cruz, N Aït-Khaled, CE Baena-Cagnani, ... Journal of Allergy and Clinical Immunology 126 (5), 926-938, 2010 | 1029 | 2010 |
| Tiotropium versus salmeterol for the prevention of exacerbations of COPD C Vogelmeier, B Hederer, T Glaab, H Schmidt, MPMH Rutten-van Mölken, ... New England Journal of Medicine 364 (12), 1093-1103, 2011 | 980 | 2011 |
| From COPD to chronic systemic inflammatory syndrome? LM Fabbri, KF Rabe The Lancet 370 (9589), 797-799, 2007 | 977 | 2007 |
| Severity of airflow limitation is associated with severity of airway inflammation in smokers A DI STEFANO, A Capelli, M LUSUARDI, P Balbo, C Vecchio, P Maestrelli, ... American journal of respiratory and critical care medicine 158 (4), 1277-1285, 1998 | 856 | 1998 |
| Cellular and structural bases of chronic obstructive pulmonary disease M Saetta, G Turato, P Maestrelli, CE Mapp, LM Fabbri American journal of respiratory and critical care medicine 163 (6), 1304-1309, 2001 | 855 | 2001 |
| Airway eosinophilia in chronic bronchitis during exacerbations. M Saetta, A Di Stefano, P Maestrelli, G Turato, MP Ruggieri, A Roggeri, ... American journal of respiratory and critical care medicine 150 (6), 1646-1652, 1994 | 769 | 1994 |
| Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials LM Fabbri, PMA Calverley, JL Izquierdo-Alonso, DS Bundschuh, M Brose, ... The Lancet 374 (9691), 695-703, 2009 | 752 | 2009 |
| Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study G Ferrara, M Losi, R D'Amico, P Roversi, R Piro, M Meacci, B Meccugni, ... The Lancet 367 (9519), 1328-1334, 2006 | 730 | 2006 |
| CD8+ ve cells in the lungs of smokers with chronic obstructive pulmonary disease M Saetta, S Baraldo, L Corbino, G Turato, F Braccioni, F Rea, ... American journal of respiratory and critical care medicine 160 (2), 711-717, 1999 | 712 | 1999 |
| Global strategy for the diagnosis, management and prevention of COPD: 2003 update LM Fabbri, SS Hurd, GOLD Scientific Committee European Respiratory Journal 22 (1), 1-1, 2003 | 709 | 2003 |
| Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease LM Fabbri, M Romagnoli, L Corbetta, G Casoni, K Busljetic, G Turato, ... American journal of respiratory and critical care medicine 167 (3), 418-424, 2003 | 707 | 2003 |
| Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial A Papi, J Vestbo, L Fabbri, M Corradi, H Prunier, G Cohuet, A Guasconi, ... The Lancet 391 (10125), 1076-1084, 2018 | 665 | 2018 |
Marina SaettaProfessore Ordinario, Università degli Studi di Padova確認したメール アドレス: unipd.it